Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,824 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and effectiveness of antipsychotic medication for delirium in patients with advanced cancer: A large-scale multicenter prospective observational study in real-world palliative care settings.
Maeda I, Ogawa A, Yoshiuchi K, Akechi T, Morita T, Oyamada S, Yamaguchi T, Imai K, Sakashita A, Matsumoto Y, Uemura K, Nakahara R, Iwase S; Phase-R Delirium Study Group. Maeda I, et al. Among authors: uemura k. Gen Hosp Psychiatry. 2020 Nov-Dec;67:35-41. doi: 10.1016/j.genhosppsych.2020.09.001. Epub 2020 Sep 14. Gen Hosp Psychiatry. 2020. PMID: 32950826
Current Pharmacotherapy Does Not Improve Severity of Hypoactive Delirium in Patients with Advanced Cancer: Pharmacological Audit Study of Safety and Efficacy in Real World (Phase-R).
Okuyama T, Yoshiuchi K, Ogawa A, Iwase S, Yokomichi N, Sakashita A, Tagami K, Uemura K, Nakahara R, Akechi T; Phase‐R Delirium Study Group. Okuyama T, et al. Among authors: uemura k. Oncologist. 2019 Jul;24(7):e574-e582. doi: 10.1634/theoncologist.2018-0242. Epub 2019 Jan 4. Oncologist. 2019. PMID: 30610009 Free PMC article.
Effect of olanzapine orally disintegrating tablet versus oral standard tablet on body weight in patients with schizophrenia: a randomized open-label trial.
Kusumi I, Honda M, Uemura K, Sugawara Y, Kohsaka M, Tochigi A, Koyama T. Kusumi I, et al. Among authors: uemura k. Prog Neuropsychopharmacol Biol Psychiatry. 2012 Mar 30;36(2):313-7. doi: 10.1016/j.pnpbp.2011.11.004. Epub 2011 Nov 15. Prog Neuropsychopharmacol Biol Psychiatry. 2012. PMID: 22119746 Clinical Trial.
Screening for diabetes using monitoring guidance in schizophrenia patients treated with second-generation antipsychotics: a 1-year follow-up study.
Kusumi I, Ito K, Uemura K, Honda M, Hayashishita T, Miyamoto K, Sawayama H, Kako Y, Tsuchida S, Hashimoto N, Koyama T. Kusumi I, et al. Among authors: uemura k. Prog Neuropsychopharmacol Biol Psychiatry. 2011 Dec 1;35(8):1922-6. doi: 10.1016/j.pnpbp.2011.07.003. Epub 2011 Jul 23. Prog Neuropsychopharmacol Biol Psychiatry. 2011. PMID: 21807061
Screening for diabetes using Japanese monitoring guidance in schizophrenia patients treated with second-generation antipsychotics: a cross-sectional study using baseline data.
Kusumi I, Ito K, Honda M, Hayashishita T, Uemura K, Hashimoto N, Murasaki M, Atsumi Y, Kadowaki T, Koyama T. Kusumi I, et al. Among authors: uemura k. Psychiatry Clin Neurosci. 2011 Jun;65(4):349-55. doi: 10.1111/j.1440-1819.2011.02218.x. Epub 2011 May 5. Psychiatry Clin Neurosci. 2011. PMID: 21545674 Free article.
The Whole Picture of First-Line Osimertinib for EGFR Mutation-Positive Advanced NSCLC: Real-World Efficacy, Safety, Progression Pattern, and Posttreatment Therapy (Reiwa Study).
Watanabe K, Hosomi Y, Naoki K, Nakahara Y, Tsukita Y, Matsumoto H, Yoh K, Fujisaka Y, Takahashi S, Takata S, Usui K, Kishi K, Naka G, Tamano S, Uemura K, Kunitoh H. Watanabe K, et al. Among authors: uemura k. JTO Clin Res Rep. 2024 Sep 7;5(11):100720. doi: 10.1016/j.jtocrr.2024.100720. eCollection 2024 Nov. JTO Clin Res Rep. 2024. PMID: 39416709 Free PMC article.
1,824 results